SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y. Han, H. Zhao, Q. Jiang, H. Gao, C. Wang, Chemopreventive mechanism of polypeptides from Chlamy Farreri (PCF) against UVB-induced malignant transformation of HaCaT cells, Mutagenesis, 2015, 30, 2, 287

    CrossRef

  2. 2
    Cleo Robinson, Ian M. Dick, Michael J. Wise, Andrew Holloway, Dileepa Diyagama, Bruce W. S. Robinson, Jenette Creaney, Richard A. Lake, Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma, BMC Cancer, 2015, 15, 1

    CrossRef

  3. 3
    I Tanaka, H Osada, M Fujii, A Fukatsu, T Hida, Y Horio, Y Kondo, A Sato, Y Hasegawa, T Tsujimura, Y Sekido, LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade, Oncogene, 2015, 34, 1, 73

    CrossRef

  4. 4
    Birgitta I. Hiddinga, Christian Rolfo, Jan P. van Meerbeeck, Mesothelioma treatment: Are we on target? A review, Journal of Advanced Research, 2015, 6, 3, 319

    CrossRef

  5. 5
    Ying Chen, Zhao-yan Wang, Hao Wu, P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas, European Archives of Oto-Rhino-Laryngology, 2015, 272, 9, 2227

    CrossRef

  6. 6
    Georgia Karpathiou, Dimitrios Stefanou, Marios E. Froudarakis, Pleural neoplastic pathology, Respiratory Medicine, 2015, 109, 8, 931

    CrossRef

  7. 7
    M. B. Suraokar, M. I. Nunez, L. Diao, C. W. Chow, D. Kim, C. Behrens, H. Lin, S. Lee, G. Raso, C. Moran, D. Rice, R. Mehran, J. J. Lee, H. I. Pass, J. Wang, A. A. Momin, B. P. James, A. Corvalan, K. Coombes, A. Tsao, I. I. Wistuba, Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications, Annals of Oncology, 2014, 25, 6, 1184

    CrossRef

  8. 8
    Özgür Özyılkan, Malignant pleural mesothelioma: A single-center experience in Turkey, Medical Science Monitor, 2014, 20, 825

    CrossRef

  9. 9
    Yong-Ming Zhou, Juan Liu, Wei Sun, MiR-130a Overcomes Gefitinib Resistance by Targeting Met in Non-Small Cell Lung Cancer Cell Lines, Asian Pacific Journal of Cancer Prevention, 2014, 15, 3, 1391

    CrossRef

  10. 10
    Leonardo Vinícius Monteiro de Assis, Jamille Locatelli, Mauro César Isoldi, The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1845, 2, 232

    CrossRef

  11. 11
    Miho Izumikawa, Masashi Itoh, Teppei Kawahara, Noriaki Sakata, Toshio Tsuchida, Kazuo Shin-ya, Correction of the structure of cuevaene A and its identity with MBJ-0020 from Streptomyces sp. 30503, The Journal of Antibiotics, 2013, 66, 9, 563

    CrossRef

  12. 12
    P. Andujar, J.-C. Pairon, A. Renier, A. Descatha, I. Hysi, I. Abd-Alsamad, M.-A. Billon-Galland, H. Blons, B. Clin, C. Danel, D. Debrosse, F. Galateau-Salle, B. Housset, P. Laurent-Puig, F. Le Pimpec-Barthes, M. Letourneux, I. Monnet, J.-F. Regnard, P. Validire, J. Zucman-Rossi, M.-C. Jaurand, D. Jean, Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma, Mutagenesis, 2013, 28, 3, 323

    CrossRef

  13. 13
    Jilong Yang, Xiaoling Du, Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy, Surgical Oncology, 2013, 22, 3, e53

    CrossRef

  14. 14
    Anastasia Luca, Francesca Pellizzari Tregno, Andrea Sau, Anna Pastore, Camilla Palumbo, Angela Alama, Rosella Cicconi, Giorgio Federici, Anna M. Caccuri, Glutathione S-transferase P1-1 as a target for mesothelioma treatment, Cancer Science, 2013, 104, 2
  15. 15
    Geula Klorin, Ester Rozenblum, Oleg Glebov, Robert L. Walker, Yoonsoo Park, Paul S. Meltzer, Ilan R. Kirsch, Frederic J. Kaye, Anna V. Roschke, Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines, Cancer Genetics, 2013, 206, 5, 191

    CrossRef

  16. 16
    Brooke T. Mossman, Arti Shukla, Nicholas H. Heintz, Claire F. Verschraegen, Anish Thomas, Raffit Hassan, New Insights into Understanding the Mechanisms, Pathogenesis, and Management of Malignant Mesotheliomas, The American Journal of Pathology, 2013, 182, 4, 1065

    CrossRef

  17. 17
    Toshiko Kajiwara, Kazuyuki Matsushita, Sakae Itoga, Mai Tamura, Nobuko Tanaka, Takeshi Tomonaga, Hisahiro Matsubara, Hideaki Shimada, Yasuaki Habara, Masafumi Matsuo, Fumio Nomura, SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues, Cancer Science, 2013, 104, 2
  18. 18
    Yi Zhang, Jianxing He, Fang Zhang, Hui Li, Dongsheng Yue, Changli Wang, David M Jablons, Biao He, Natalie Lui, SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma, Journal of Experimental & Clinical Cancer Research, 2013, 32, 1, 7

    CrossRef

  19. 19
    Kota Iwahori, Satoshi Serada, Minoru Fujimoto, Barry Ripley, Shintaro Nomura, Hiroyuki Mizuguchi, Kazuki Shimada, Tsuyoshi Takahashi, Ichiro Kawase, Tadamitsu Kishimoto, Tetsuji Naka, SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma, International Journal of Cancer, 2013, 132, 2
  20. 20
    Guligena Tuerdi, Saki Ichinomiya, Hiromi Sato, Sana Siddig, Eriko Suwa, Hiroki Iwata, Tomohiro Yano, Koichi Ueno, Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells, Cancer Letters, 2013, 339, 1, 116

    CrossRef

  21. 21
    Miho Izumikawa, Takahiro Hosoya, Motoki Takagi, Kazuo Shin-ya, A new cyclizidine analog—JBIR-102—from Saccharopolyspora sp. RL78 isolated from mangrove soil, The Journal of Antibiotics, 2012, 65, 1, 41

    CrossRef

  22. 22
    Futoshi Ishiguro, Hideki Murakami, Tetsuya Mizuno, Makiko Fujii, Yutaka Kondo, Noriyasu Usami, Kohei Yokoi, Hirotaka Osada, Yoshitaka Sekido, Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma, Journal of Thoracic Oncology, 2012, 7, 5, 890

    CrossRef

  23. 23
    Motoki Takagi, Kazuo Shin-ya, Construction of a natural product library containing secondary metabolites produced by actinomycetes, The Journal of Antibiotics, 2012, 65, 9, 443

    CrossRef

  24. 24
    Valerio Izzi, Laura Masuelli, Ilaria Tresoldi, Calogero Foti, Andrea Modesti, Roberto Bei, Immunity and malignant mesothelioma: From mesothelial cell damage to tumor development and immune response-based therapies, Cancer Letters, 2012, 322, 1, 18

    CrossRef

  25. 25
    Didier Jean, Julien Daubriac, Françoise Le Pimpec-Barthes, Françoise Galateau-Salle, Marie-Claude Jaurand, Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment, Archives of Pathology & Laboratory Medicine, 2012, 136, 3, 277

    CrossRef

  26. 26
    Seiki Hasegawa, Nobuyuki Kondo, Seiji Matsumoto, Teruhisa Takuwa, Masaki Hashimoto, Hayato Orui, Shunichi Fukuda, Kazue Yoneda, Yoshitomo Okumura, Noriaki Tsubota, Kazuya Fukuoka, Ikuko Torii, Tohru Tsujimura, Takashi Nakano, Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy, International Journal of Clinical Oncology, 2012, 17, 1, 33

    CrossRef

  27. 27
    Makiko Fujii, Takeshi Toyoda, Hayao Nakanishi, Yasushi Yatabe, Ayuko Sato, Yasue Matsudaira, Hidemi Ito, Hideki Murakami, Yutaka Kondo, Eisaku Kondo, Toyoaki Hida, Tohru Tsujimura, Hirotaka Osada, Yoshitaka Sekido, TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth, The Journal of Experimental Medicine, 2012, 209, 3, 479

    CrossRef

  28. 28
    T Mizuno, H Murakami, M Fujii, F Ishiguro, I Tanaka, Y Kondo, S Akatsuka, S Toyokuni, K Yokoi, H Osada, Y Sekido, YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes, Oncogene, 2012, 31, 49, 5117

    CrossRef

  29. 29
    Emanuela Felley-Bosco, Isabelle Opitz, Lung Cancer Therapy Annual 7, 2012,

    CrossRef

  30. 30
    Emanuela Felley-Bosco, Isabelle Opitz, Lung Cancer Therapy Annual 7, 2012,

    CrossRef

  31. 31
    Takemi OTSUKI, Takashi NAKANO, Seiki HASEGAWA, Morihito OKADA, Tohru TSUJIMURA, Yoshitaka SEKIDO, Shinya TOYOKUNI, Hiroshi NISHIMOTO, Kazuya FUKUOKA, Fumihiro TANAKA, Naoko KUMAGAI, Megumi MAEDA, Yasumitsu NISHIMURA, Archives of “Comprehensive Approach on Asbestos-Related Diseases” Supported by the “Special Coordination funds for Promoting Science and Technology (H18-1-3-3-1)”, Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 2011, 66, 3, 543

    CrossRef

  32. You have full text access to this Open Access content32
    Hirotaka Nagai, Toshikazu Ishihara, Wen-Hua Lee, Hiroki Ohara, Yasumasa Okazaki, Katsuya Okawa, Shinya Toyokuni, Asbestos surface provides a niche for oxidative modification, Cancer Science, 2011, 102, 12
  33. 33
    Ji-Hwan Hwang, Motoki Takagi, Hideki Murakami, Yoshitaka Sekido, Kazuo Shin-ya, Induction of tubulin polymerization and apoptosis in malignant mesothelioma cells by a new compound JBIR-23, Cancer Letters, 2011, 300, 2, 189

    CrossRef

  34. 34
    Miho Izumikawa, Motoki Takagi, Kazuo Shin-ya, Isolation of a novel macrocyclic dilactone—JBIR-101—from Promicromonospora sp. RL26, The Journal of Antibiotics, 2011, 64, 10, 689

    CrossRef

  35. 35
    Y. Bao, Y. Hata, M. Ikeda, K. Withanage, Mammalian Hippo pathway: from development to cancer and beyond, Journal of Biochemistry, 2011, 149, 4, 361

    CrossRef

  36. 36
    Kota Iwahori, Satoshi Serada, Minoru Fujimoto, Shintaro Nomura, Tadashi Osaki, Chun Man Lee, Hiroyuki Mizuguchi, Tsuyoshi Takahashi, Barry Ripley, Meinoshin Okumura, Ichiro Kawase, Tadamitsu Kishimoto, Tetsuji Naka, Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma, International Journal of Cancer, 2011, 129, 4
  37. 37
    Sarah X. L. Huang, Marie-Claude Jaurand, David W. Kamp, John Whysner, Tom K. Hei, Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases, Journal of Toxicology and Environmental Health, Part B, 2011, 14, 1-4, 179

    CrossRef

  38. 38
    Naoko KUMAGAI, Yasumitsu NISHIMURA, Megumi MAEDA, Hiroaki HAYASHI, Takemi OTSUKI, Immunological Effects of Silica/Asbestos, Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene), 2010, 65, 4, 493

    CrossRef

  39. 39
    Marcello Lotti, Lorenzo Bergamo, Bruno Murer, Occupational toxicology of asbestos-related malignancies, Clinical Toxicology, 2010, 48, 6, 485

    CrossRef